34 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
encephalitis • Mycobacterium ... tuberculosis infection ... • Disseminated Mycobacterium ... A and B virus infection ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
encephalitis • Mycobacterium ... tuberculosis infection ... • Disseminated Mycobacterium ... A and B virus infection ... IDSA #management #pharmacology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... /day or weekly injection ... (ER version) ... side effects (e.g ... Receptor #Agonists #Pharmacology
Non-Resolving Pneumonias: Etiologies
Unusual Infections:
 - Immunocompromised patients (e.g.: Mycobacterium, Aspergillosis, Nocardia)
 - Endemic Fungi (e.g.: Histoplasmosis,
Etiologies Unusual Infections ... .: Mycobacterium ... Endemic Fungi (e.g ... - Zoonotic (e.g ... Returning travelers (e.g
Hydroxychloroquine in COVID-19 - How might hydroxychloroquine help combat a COVID-19 infection?

It's important to remember that
combat a COVID-19 infection ... ATL MedStudent COVID ... #Coronavirus #Pharmacology
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
developing active infection ... • Tuberculosis infection ... immunocompromised (e.g ... Mycobacterial culture ... • AFB stain • Mycobacterial
Causes of Erythema Nodosum
Common
 - Idiopathic (up to 55 percent)
 - Infections: streptococcal pharyngitis (28 to
55 percent) - Infections ... coccidioidomycosis, mycobacteria ... : antibiotics (e.g ... 1 percent) Infections
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
Bydureon (Exenatide ER ... are subcutaneous injections ... GI tract) and injection ... GLP1 #Agonists #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... Weight loss (~2-3kg ... hypovolemia) • GU infections ... (e.g. ... SGLT2 #Inhibitors #Pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... ., 4 mg/kg on days ... opportunistic #infections ... #HIVAIDS #pharmacology